Abstract
The inhibitory effects on tyrosinase activity by extracts of several mushrooms belonging to Basidiomycetes were evaluated. Among the tested mushrooms (Ganoderma lucidum, Antrodia camphorata, Agaricus brasiliensis, and Cordyceps militaris), G. lucidum exhibited significant inhibition of tyrosinase activity (IC50 value 0.32 mg/ml), compared to those prepared from other Basidiomycetes. Tyrosinase inhibitors are effective components of skin-lightening compounds and other cosmetics; currently many of the facial mask cosmetics in the market contain Ganoderma extracts in their ingredients. The finding that mushroom extracts contain tyrosinase activity inhibition will contribute to better understanding of how their ‘healing’ properties in various Chinese traditional herbal on skin care products.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Ganoderma lucidum (also known as “Lingzhi” in the herbal medicine community) is a Basidiomycete which is highly valued as a traditional Chinese herb. It is believed to contribute to a person’s longevity. The extracts of Ganoderma lucidum include bioactive compounds like polysaccharides, triterpenoids, alkaloids, enzymes, and proteins (including glycoprotein) [1]. Numerous pharmacological studies have demonstrated that various extracts of Ganoderma spp. contain immunomodulatory, antiperoxidative, and anti-tumor activities [2–6]. Additionally, other studies also reported that the extracts from these medicinal mushrooms could facilitate skin wound healing [7, 8]. “Lingzhi” is also highly popular as a health supplement and is often used to combat fatigue [2, 9].
“Lingzhi” is a common ingredient in various cosmetic lines and may contribute to the whitening of skin. This property is highly valued by many oriental (Chinese and Japanese) women [7, 8, 10]. Skin-whitening is believed to be partly due to the inhibition of tyrosinase activity, and various skin-whitening cosmetics are believed to be effective because of the presence of arbutin or kojic acid which act as tyrosinase inhibitors [11–13]. Tyrosinase is a copper-containing enzyme present in plant and animal tissues that catalyzes the production of melanin and other pigments from tyrosine by oxidation [14].
In this study, we aim to evaluate the effectiveness of the extracts of Ganoderma lucidum and related Basidiomycetes in tyrosinase inhibition and thus its usefulness as a skin whitener.
Materials and Methods
Preparation of Mushroom Extracts
The Basidiomycetes Ganoderma lucidum, Antrodia camphorata (Antrodia cinnamomea), Agaricus brasiliensis (Agaricus blazei Murill), and Cordyceps militaris were purchased from Bioresource Collection and Research Center (BCRC), Food Industry Research and Development Institute, Hsinchu, Taiwan. Cultures of the Basidiomycetes were grown in 1,000-ml Erlenmeyer flasks containing 200 ml potato dextrose broth (BD Diagnostics, Spark, MD, USA) and incubated at 25°C with 100 rpm shaking for 7 days. The mycelia were then filtered using Whatman Grade No. 1 filter paper (VWR International, West Chester, PA, USA), lyophilized, and powered before use. Dried mycelium powder (5 g) was extracted first with 70% (v/v) ethanol, 50% (v/v) ethanol, and distilled water at room temperature for 3 days, respectively. Extracts were filtrated, pooled, and the water allowed evaporating completely in a rota vapor at mild temperature (40°C). The dry residues were finally dissolved in distilled water into different concentrations for further experiments.
Determination of Inhibitory Effect on Tyrosinase Activity of the Extracts
Extracts of G. lucidum, A. camphorata, A. brasiliensis, and C. militaris were diluted to different concentrations to assay for tyrosinase inhibition. One hundred-microliter tyrosinase (350 units/ml; Sigma, St. Louis, MO, USA) was mixed with 0.9 ml of various concentration of extracts prepared as described above (0.1 and 1 mg/ml) in phosphate buffer (pH 6.8) and 1 ml of l-tyrosine (1 mmol/l). The reaction mixture was incubated at 37°C for 25 min. Absorbance at 280 nm was measured to determine the activity of tyrosinase [15]. Experimental controls were performed with the same reaction mixture in the absence of extracts with or without tyrosinase. The inhibition rate of tyrosinase activity was calculated as the inhibition (%) = [1 − (B −B 0)/(A − A 0)] × 100, where A and A 0 represent the absorbance of control with and without tyrosinase, respectively; B and B 0 represent the absorbance of the experimental sample with and without tyrosinase, respectively.
Results and Discussion
The inhibitory effects on tyrosinase activity by the extracts of the different mushrooms are shown in Figs. 1 and 2. Among the extracts examined, all extracts prepared from G. lucidum showed significant inhibition of tyrosinase activity (IC50 value was about 0.32 mg/ml). About 80% of tyrosinase activity was inhibited when the reaction mixture contained 1 mg/ml of the extract (Fig. 1), and still about 40% of inhibition effect was observed when the reaction mixture contained 0.1 mg/ml of the extract (Fig. 2). No difference in inhibitory effects on tyrosinase activity was observed by G. lucidum extracts obtained by the three different extraction methods (75%, 50% ethanol, and distilled water extraction). The only other extract that showed some inhibitory effect on tyrosinase activity was prepared from A. camphorata using 75% ethanol extraction (IC50 was about 1 mg/ml) (Fig. 1). Extracts of A. camphorata prepared by 50% extraction and distilled water, and all extracts prepared from A. brasiliensis and C. militaris showed less than 25% inhibition in the reaction mixtures contained 1 mg/ml extracts (Fig. 1). No significant inhibitory effect on tyrosinase activity was observed when 0.1 mg/ml extracts were used in the reaction mixture (Fig. 2).
We subsequently examined four different strains of G. lucidum for their ability to inhibit tyrosinase activity. The reaction mixtures contained 1 mg/ml distilled water extraction of mycelia of the four G. lucidum. Mycelia from these four strains of G. lucidum were washed with distilled water twice before extraction and used for the experiment. Inhibitory effects on tyrosinase activity were still evident (IC50 was about 1 mg/ml), although the inhibition rate was lower than extracts prepared from mycelia (This was obtained by removing the mycelia from cultured medium using filtration with a Whatman Grade No. 1 filter paper; Fig. 1) This implies that the active components of the inhibition are water soluble.
Tyrosinase inhibitors are effective components of skin-lightening compounds and cosmetics [13, 16, 17]. Some traditional Chinese herbal medicines have been investigated for their potential use in various lines of cosmetic products, and the extracts of Pharbitis nil, Sophora japonica, Spatholobus suberectus, and Morus alba showed potent tyrosinase inhibitory effects [18]. The Basidiomycete Ganoderma is often regarded as a panacea in traditional Chinese culture. Recent scientific studies have demonstrated that Ganoderma can be a remedy to many diseases such as hepatopathy, chronic hepatitis, nephritis, hypertension, etc. [2]. The extracts of the mycelium of G. lucidum have also been demonstrated to have antiperoxidative, anti-inflammatory antimutagenic activities, and antioxidant properties [3, 19]. The residues of fruiting body of Ganoderma tsugae exhibit the effect of promoting skin wound healing [7, 8]. G. lucidum extracts were also shown to exert immunomodulating and anticancer effects [20]. Laccase activity has been detected from fresh fruiting bodies of G. lucidum, and a laccase gene from G. lucidum has also been cloned and expressed for studying its antioxidative properties [21, 22]. Whether these enzyme activities are related to the nature of tyrosinase inhibition is to be examined in the future. Currently, many of the facial mask cosmetics in the market contain Ganoderma in their ingredients. However, there are no reports presently on Ganoderma being the potential source of tyrosinase inhibitors and this could be the direct effect of ‘skin-whitening’. In this study, we demonstrate for the first time that extracts of G. lucidum contain tyrosinase-inhibiting activities. The extracts also do not show any toxicity to human fibroblast Hs68 (results not shown). This trait may contribute to the effectiveness of this Chinese traditional herbal on skin care and cosmetology.
The composition of fruiting body and/or mycelia of G. lucidum were very complicated, and it is still hard at present stage to identify which component(s) attribute to the inhibitory effect [1, 9, 23, 24]. The active constituents of G. lucidum on various diseases or health function can be very different such as polysaccharides and triterpenes [24, 25]. G. lucidum are widely used as health food additives and now appear in some cosmetic additives. Results of this study suggested another possible mechanism of this magic traditional Chinese medicinal herbal on its effectives of preventing aging and may also be useful as additives in skin care cosmetics.
References
Huie CW, Di X. Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. J Chromatogr B. 2004;812:241–57.
Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol. 1992;37:101–34.
Lakshmi B, Ajith TA, Sheena N, Gunapalan N, Janardhanan KK. Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of mycelium of Ganoderma lucidum occurring in south India. Teratog Carcinog Mutagen Suppl. 2003;1:85–97.
Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin. 2004;25:1387–95.
Yuen JW, Gohel MD. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer. 2005;53:11–7.
Zhou X, Lin J, Yin Y, Zhao J, Sun X, Tang K. Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med. 2007;35:559–74.
Hung WS, Fang CL, Su CH, Lai WF, Chang YC, Tsai YH. Cytotoxicity and immunogenicity of SACCHACHITIN and its mechanism of action on skin wound healing. J Biomed Mater Res. 2001;56:93–100.
Hung WS, Lai WF, Leu B, Su CH, Fang CL, Tsai YH. Effect of SACCHACHITIN on keratinocyte proliferation and the expressions of type I collagen and tissue-transglutaminase during skin wound healing. J Biomed Mater Res. 2004;70:122–9.
Mizuno T. Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. Food Rev Int. 1995;11:7–21.
Su CH, Sun CS, Juan SW, Hu CH, Ke WT, Sheu MT. Fungal mycelia as the source of chitin and polysaccharides and their applications as skin substitutes. Biomaterials. 1997;18:1169–74.
Burdock GA, Soni MG, Carabin IG. Evaluation of health aspects of kojic acid in food. Regul Toxicol Pharmacol. 2001;33:80–101.
Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20–31.
Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Kuriki T. Inhibitory effects of α-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biol Pharm Bull. 2004;27:510–4.
Hearing VJ, Jimenez M. Mammalian tyrosinase—the critical regulatory control point in melanocyte pigmentation. Int J Biochem. 1987;19:1141–7.
Duckworth HW, Coleman JE. Physicochemical and kinetic properties of mushroom tyrosinase. J Biol Chem. 1970;245:1613–25.
An BJ, Kwak JH, Park JM, Lee JY, Park TS, Lee JT, et al. Inhibition of enzyme activities and the antiwrinkle effect of polyphenol isolated from the persimmon leaf (Diospyros kaki folium) on human skin. Dermatol Surg. 2005;31:848–54.
Yoshimura M, Watanabe Y, Kasai K, Yamakoshi J, Koga T. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem. 2005;69:2368–73.
Wang KH, Lin RD, Hsu FL, Huang YH, Chang HC, Huang CY, et al. Cosmetic applications of selected traditional Chinese herbal medicines. J Ethnopharmacol. 2006:106:353–9.
Mau JL, Lin HC, Chen CC. Antioxidant properties of several medicinal mushrooms. J Agric Food Chem. 2002;50:6072–7.
Chan WK, Lam DT, Law HK, Wong WT, Koo MW, Lau AS, et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med. 2005;11:1047–57.
Wang HX, Ng TB. A laccase from the medicinal mushroom Ganoderma lucidum. Appl Microbiol Biotechnol. 2006;72:508–13.
Joo SS, Ryu IW, Park JK, Yoo YM, Lee DH, Hwang KW, et al. Molecular cloning and expression of a laccase from Ganoderma lucidum, and its antioxidative properties. Mol Cells. 2008;25:112–8.
Di X, Chan KK, Leung HW, Huie CW. Fingerprint profiling of acid hydrolyzates of polysaccharides extracted from the fruiting bodies and spores of Lingzhi by high-performance thin-layer chromatography. J Chromatogr A. 2003;1018:85–95.
Lin SB, Li CH, Lee SS, Kan LS. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci. 2003;72:2381–90.
Park EJ, Ko G, Kim J, Sohn DH. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull. 1997;20:417–20.
Acknowledgments
This work was supported in part by a grant (contract number NSC95-2221-E-155-021) from National Science Council, Taiwan. We are also grateful to Dr. Thomas J. Lie, University of Washington, Seattle, USA, for the editing assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chien, CC., Tsai, ML., Chen, CC. et al. Effects on Tyrosinase Activity by the Extracts of Ganoderma lucidum and Related Mushrooms. Mycopathologia 166, 117–120 (2008). https://doi.org/10.1007/s11046-008-9128-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-008-9128-x